To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers
Status:
Completed
Trial end date:
2018-03-29
Target enrollment:
Participant gender:
Summary
This clinical study will be conducted to characterize the gastrointestinal transit of two
multi-symptoms formulations by inclusion of a radiolabel marker.